Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab

Bernd Schultes; Barbara Ernst; Sebastian M. Schmid

doi:10.1007/s00592-021-01776-w

Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab

Bernd Schultes^*, Barbara Ernst, Sebastian M. Schmid

^*Corresponding author for this work

friendlyDocs Ltd.

1 Citation (Scopus)

Original language	English
Journal	Acta Diabetologica
Volume	58
Issue number	11
Pages (from-to)	1575-1577
Number of pages	3
ISSN	0940-5429
DOIs	https://doi.org/10.1007/s00592-021-01776-w
Publication status	Published - 11.2021

Research Areas and Centers

Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

DFG Research Classification Scheme

2.22-17 Endocrinology, Diabetology, Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00592-021-01776-w

Cite this

@article{d1525a0ff4f24b26adc44bc4c897b29f,

title = "Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab",

author = "Bernd Schultes and Barbara Ernst and Schmid, \{Sebastian M.\}",

year = "2021",

month = nov,

doi = "10.1007/s00592-021-01776-w",

language = "English",

volume = "58",

pages = "1575--1577",

journal = "Acta Diabetologica",

issn = "0940-5429",

publisher = "Springer-Verlag Italia s.r.l.",

number = "11",

}

Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab. / Schultes, Bernd; Ernst, Barbara; Schmid, Sebastian M.
In: Acta Diabetologica, Vol. 58, No. 11, 11.2021, p. 1575-1577.

Research output: Journal Articles › Journal articles › Research › peer-review

TY - JOUR

T1 - Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab

AU - Schultes, Bernd

AU - Ernst, Barbara

AU - Schmid, Sebastian M.

PY - 2021/11

Y1 - 2021/11

UR - https://www.scopus.com/pages/publications/85112091628

U2 - 10.1007/s00592-021-01776-w

DO - 10.1007/s00592-021-01776-w

M3 - Journal articles

C2 - 34370095

AN - SCOPUS:85112091628

SN - 0940-5429

VL - 58

SP - 1575

EP - 1577

JO - Acta Diabetologica

JF - Acta Diabetologica

IS - 11

ER -

Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Cite this